It is thus likely that pathogenic Th17 cells may have different roles at different phases of RA: IL-17-producing Th17 cells for the initiation in an early phase and GM-CSF-producing ex-Th17 cells for chronic inflammation in a later phase. Here, IL17A is linked to rheumatoid arthritis.